Arvinder Dhalla
Corporate Officer/Principal bij RANI THERAPEUTICS HOLDINGS, INC.
Profiel
Arvinder Dhalla is currently working as the Vice President of Clinical Operations at Rani Therapeutics LLC and as the Vice President of Clinical Development at Rani Therapeutics Holdings, Inc. Previously, she worked as the Biology Director of Cardiovascular Therapeutic at Gilead Sciences, Inc. from 2009 to 2015.
Dr. Dhalla holds a doctorate degree from the University of Manitoba and undergraduate and graduate degrees from Panjab University Chandigarh.
Actieve functies van Arvinder Dhalla
| Bedrijven | Functie | Begin |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | - |
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Chief Operating Officer | - |
Eerdere bekende functies van Arvinder Dhalla
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-01-2015 |
Opleiding van Arvinder Dhalla
| University of Manitoba | Doctorate Degree |
| Panjab University Chandigarh | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| RANI THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Health Technology |
